{"name":"Università Vita-Salute San Raffaele","slug":"universit-vita-salute-san-raffaele","ticker":"","exchange":"","domain":"","description":"Vita-Salute San Raffaele University is a private, not for-profit university in Milan, Italy. The university was founded in 1996 within the Opera San Raffaele by Don Luigi Maria Verzé, who was its rector until his death in 2011. The university is affiliated with the San Raffaele Hospital in Milan, which in 2012 became part of the San Donato Hospital Group.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Phosphocreatine","genericName":"Phosphocreatine","slug":"phosphocreatine","indication":"Other","status":"phase_3"},{"name":"desflurane, isoflurane, sevoflurane","genericName":"desflurane, isoflurane, sevoflurane","slug":"desflurane-isoflurane-sevoflurane","indication":"Other","status":"marketed"},{"name":"total intravenous anesthetics","genericName":"total intravenous anesthetics","slug":"total-intravenous-anesthetics","indication":"Induction and maintenance of general anesthesia","status":"marketed"}]}],"pipeline":[{"name":"Phosphocreatine","genericName":"Phosphocreatine","slug":"phosphocreatine","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"desflurane, isoflurane, sevoflurane","genericName":"desflurane, isoflurane, sevoflurane","slug":"desflurane-isoflurane-sevoflurane","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"total intravenous anesthetics","genericName":"total intravenous anesthetics","slug":"total-intravenous-anesthetics","phase":"marketed","mechanism":"Total intravenous anesthetics are a class of drugs that induce and maintain general anesthesia by depressing the central nervous system through enhancement of GABAergic inhibitory neurotransmission.","indications":["Induction and maintenance of general anesthesia","Sedation in intensive care units"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-09","type":"pipeline","source":"The Chronicle-Journal","summary":"User - The Chronicle-Journal","headline":"User - The Chronicle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOQkMwT1VXTkEtOEgwQWVUMW42WkxjT291S0dXdDVCQ21PcG5sYm9STUhmODdSRi1YckJ0QzdzSWM3Q3NrUVFZMEhnM0RFNUpuOHFwT3NQV2RJMzA0S1dDcnpqOU4zR2JtMzRHa0RxRDlaQ0xfQVY3NldTUl9JeXBZbFdEYUJHRFRjcWZSMktQemplaHNGemt6dTk4ZDRaQkZRVzlSdDgxRmM0RmltY2JPQk80MEItSnV5VWtNUi1HM0x2czVNUDBwREw2emtqOVlQVjZvejA1Qkk3UTVPODljX2NCTmlpZDNqeFlyQnZkTlA3bG1RajZR?oc=5","date":"2026-02-12","type":"pipeline","source":"Business Wire","summary":"Thetis Pharmaceuticals Expands Scientific Advisory Board with Leading Experts in Inflammatory Bowel Disease - Business Wire","headline":"Thetis Pharmaceuticals Expands Scientific Advisory Board with Leading Experts in Inflammatory Bowel Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxNTkdScVptYklQRW1ZTXdrb29sRFVZS3l1N2xRWlFmR3JXWXM5Y2xnd3NjdFVJTlc4emVxcXlBYTIwRnFPVHJJbWI0X3VHQ1FFVGVXQkJIU3dDVTM5Uy1RVHljZDd2T0MxSnZBZDItWVhnQS1IeDAxUGF5Q09uNmhJOHRpR3pEcVA5U1dxVEhOYmdEczJmbVk5andHZ2tfOGh6cjMyYlB1cklnaEc2UTVmRWJuZGpObG84dHZsbDZzSTJsa21EM24zSWhyRThFeUd4TVZCMHluLVhVNmZrSE9VczNMNXd5X0d3V3BUQzBORzI?oc=5","date":"2026-02-10","type":"pipeline","source":"BioSpace","summary":"OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer - BioSpace","headline":"OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Office","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNeEJlNms4UnJKZHk2cDhsaTNlMWN0R2VOMXZQSjM5UWFYVzl6aDJuT3NpQlYzR0RSNWlVamNyaGhUSVBVR1d4bEdpdzh0cTRzVUpoVnduWE5TNlJDdkJPa0R4RlRlQU4xS0RTWVN6WlM1Y3BZUi1BWFRJZnFuV1dUX3ZVajhLb043ZTdwMVdWWl9BOVcwUjZtMnhKRUJrMHU1NDJvMg?oc=5","date":"2026-01-16","type":"pipeline","source":"The Pharma Letter","summary":"EC authorization for Waskyra for Wiskott-Aldrich syndrome - The Pharma Letter","headline":"EC authorization for Waskyra for Wiskott-Aldrich syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNRmNmTkg0VUtEa2xIeUhmMHRKdzd5SEhrWVp2a3R2N0R4ZjVIeUlkU0RlRGdxMHhRN2dKdnRtSDFiWmFXS182VEVGbUxHWXJPeC1uZmpmeXFDMUV3N3FITkFaZ0dnTFVwOF9KZVEtMTlHZHJRZlV0bDRNaXNLTXA4U2tHNFdycVhnX0R6OGFpaTlMLVBrbkY5SXByZ043eUxlOEoxOVN0M21hZC1RQ2NZODRGS0N4VEFUT1pZ?oc=5","date":"2025-09-03","type":"regulatory","source":"The Medicine Maker","summary":"This Week’s Biopharma News: Teva Wins Approval for Generic GLP-1 - The Medicine Maker","headline":"This Week’s Biopharma News: Teva Wins Approval for Generic GLP-1","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9ZWnF1Q0pBRlhUbjdhdnFFRDFFbHlWeTRTVzhPYzR1cV91S01jdE1Ka21mQnBkZXVqcDBRbHZFdFliYUg1c2M4bUxaN1A5dEZyV1pLc0lMaDA1TjJuODE1RE53?oc=5","date":"2025-08-07","type":"pipeline","source":"ACS Publications","summary":"Polydopamine Nanoparticles as a Potential Non-Pharmaceutical Antioxidant Tool against Mitochondrial Disorders - ACS Publications","headline":"Polydopamine Nanoparticles as a Potential Non-Pharmaceutical Antioxidant Tool against Mitochondrial Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPREpZLVN6aHR6X3BLci11MmVkMGEycFg5M2U3WUZma0pHM0VESHJTTWtxM3hVbllPdHBtLS1TYWZUNUlQZ0NuWGpOWl9lZlhNZ1lJMjJuMWllN0xnTEZoSjhaamtaQldLOUxxZzVWOTE5SFdCa0VvY2NUODE1WWZkT2plSVdCaVpmelNEMjFjQ19oQm1fWmJqSGxLVUQySmk4dEFKQVo3bGY?oc=5","date":"2025-08-01","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces – Board of Director and Advisory Board hires for June 2025 - pharmaphorum","headline":"Changing Faces – Board of Director and Advisory Board hires for June 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOUFBGc1NobXphWXNvQWhfRVlMNU82YU1NUHBXeEVablNFQXRZZ0pOZzFPREJZQ1Vkc1QtUHE0UzZrZGxNSTBYbzlhSUhSM3dKSE5qYzh2QVozRXlSRGV4QzJfVXQ4V2tZZ0h6dEdkb1lERWk4ZjZSUEc1SFZxX2NLNXUyQWhVbFlhSVY1cV9UZjZITTdDUVNWTQ?oc=5","date":"2025-05-20","type":"pipeline","source":"Plataforma Media","summary":"Telix at ANZSNM Annual Scientific Meeting 2025 - Plataforma Media","headline":"Telix at ANZSNM Annual Scientific Meeting 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOalJMd3BMMlo3Yk84azhUV0NKZDF2UlBud2JnVDNSNHk2LWw5TU0xQnpROUJQUnlIQlg3NTBUZHVpRmVKNGdGdzNPY08yRnJTeHh5bHdHZ0dmYWhmcEtLOVNQdEhwZ2QzV2hsRkZZeC1RclFKXzQwZkxWS1B6RnctVjJQX25leExPTl9UNDJ3MnBMbmdyUnhCUmVyamJFTjRHTVJpQQ?oc=5","date":"2025-03-03","type":"regulatory","source":"PharmTech.com","summary":"EMA Gives Positive Opinion to Lilly Treatment for Chronic Lymphocytic Leukemia - PharmTech.com","headline":"EMA Gives Positive Opinion to Lilly Treatment for Chronic Lymphocytic Leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOT3NQdEd6bTJONzZNanVoV0xXcmZzOWdnUHZIRGVPOUs4RkpUb1ZyekdFdHJwY0FLREd1a3dueUFEWkN3cFdxVHE1TTk2cExEdXRnNExXTV9PdGJjRTg3NEExWmdpbnFLcXpoQV9MMHg1YUQ0UWFWRkYwbVZOaDVrLXRkaXAtV19DbThoQ3FoWEczTE9WMzBEck9EU25jNWt5WlhlSjBxRHpVNF9odjRlUDB1Q1pnYm0xNTVuVTI4N0xWd0lhQWFSV1hTaWpzSlh1RFhVNkVfRGRFM1EwUm0zcFlXNjVNWFQxQXpwSkFLbXJicnktd2RlcQ?oc=5","date":"2025-03-03","type":"pipeline","source":"Ricerca Malattie Genetiche Rare","summary":"A platform dedicated to Duchenne Muscular Dystrophy - Ricerca Malattie Genetiche Rare","headline":"A platform dedicated to Duchenne Muscular Dystrophy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPdnBvUXlEdFNFVC1hSktEaTBtWXFZdkFjeVl4djEyOTQ4UzRiUldNZWE0YVZlb3MyVm9obVBoX1d3c1dlVEJIVjdIbFVCazBEU1BKT1JzTDhyR1J1YUt4bk9URUIwdDBleGhyQURvYUZORm45aEhmU1ZwNnZic3BTbm1nbmlZMi1MRUJFVHFzb1V3aGhfb0lBYS1Pdmw2T2hxN1dDV19FcXpoSTdLZm1wMEhB?oc=5","date":"2024-12-18","type":"trial","source":"Oncology News Central","summary":"Phase 3 Data Suggest Potential New Therapeutic Option for TNBC - Oncology News Central","headline":"Phase 3 Data Suggest Potential New Therapeutic Option for TNBC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOVkZCUWxYaGNjZzBpeDJZU1RQZkV6Qkt4NE5yZ0VxcEFOaWRXRVh4YllMY2xXa3RpTTU5alVhVjk5MmVEQ09rdFhubThKVkE2djlXaE8yT1Q5WDc2cUtuUVFOQUhzUmxXWlViNVhCS1NCVHhKZW1jeTE1bzZDbGl6allYb2RUeFc3UkI5cHZmSmdUTDJYWktLYUNVYTBWbWZaRm91a0QzNA?oc=5","date":"2021-11-26","type":"regulatory","source":"European Pharmaceutical Review","summary":"EC approve Zeposia® to treat ulcerative colitis - European Pharmaceutical Review","headline":"EC approve Zeposia® to treat ulcerative colitis","sentiment":"positive"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":1,"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}